FIELD: pharmaceuticals.
SUBSTANCE: group of inventions relates to the chemical and pharmaceutical industry and is an anticancer drug for the treatment of breast cancer, which is a solution for injecting, including as active substance complex (5Z,5'Z)-2,2'-(ethane-1,2-diyldisulfanyldiyl)bis(5-(2-pyridylmethylene)-3-allyl-3,5-dihydro-4H-imidazol-4-one) with copper (II) chloride, a solvent including dimethyl sulphoxide, polysorbate 20 and poloxamer 407, and the Hemodez H diluent. Also, the inventions are represented by a method for preparing this drug, including adding the active substance in powder form to a previously prepared solvent, then sonicating the solution until the active ingredient is completely dissolved and diluting the resulting solution with Hemodez H to a therapeutically effective concentration of the active ingredient in the drug. Invention includes a method for treating breast cancer, which includes the injection administration of said drug, prepared by this method before 60 minutes after preparation of the drug in a therapeutically effective amount.
EFFECT: group of inventions ensures the stability of the obtained product within 60 minutes from the moment of its preparation until the introduction into the patient.
5 cl, 2 tbl, 325 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION INHIBITING TELOMERASE | 2014 |
|
RU2639819C2 |
TELOMERASE INHIBITORS AND METHOD FOR PRODUCTION THEREOF | 2010 |
|
RU2468030C2 |
PHARMACEUTICAL BIPHOSPHONATE APPLICATION | 2002 |
|
RU2297229C2 |
APPLICATION OF ZOLEDRONE ACID, ITS SALTS, HYDRATES AND METHOD OF ANTINOCICEPTIVE OR ANTIALLODYNIC TREATMENT OF PAIN, METHOD OF NEUROTIC PAIN TREATMENT | 2001 |
|
RU2325913C2 |
ANTICANCER PHARMACEUTICAL COMPOSITIONS AND METHOD OF TREATING BREAST CANCER | 2015 |
|
RU2581022C1 |
PHARMACEUTICAL COMPOSITION FOR USING IN THERAPY OF MALIGNANT NEOPLASM COMPRISING COMBINATION OF BISPHOSPHONATE, COX-2 INHIBITOR AND TAXOL | 2002 |
|
RU2317819C2 |
PHOTOSENSITISER OF BACTERIOCHLORINE ROW FOR PHOTODYNAMIC THERAPY AND METHOD FOR ITS PREPARATION | 2019 |
|
RU2720806C2 |
APPLYING BIS-PHOSPHONIC ACIDS FOR TREATMENT OF ANGIOGENESIS | 2000 |
|
RU2261100C2 |
ANTINEOPLASTIC AGENT | 2016 |
|
RU2623034C1 |
MONOMETHYL AURISTATIN E CONJUGATE FOR PREPARING A COMPOSITION FOR TREATING PROSTATE CANCER | 2019 |
|
RU2729192C1 |
Authors
Dates
2018-12-27—Published
2017-11-01—Filed